Recent Updates
Recently added Catalysts
CRON

Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO

Key Takeaway: Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO, April 6, 2018 - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") is pleased to announce that it has closed its previously announced bought deal public offering. A

Full Press Release Details

Cronos Group Announces Closing of
Previously Announced $100 Million Bought Deal
TORONTO, April 6, 2018 - Cronos Group
Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") is pleased to announce that it has closed
its previously announced bought deal public offering. A total of 10,420,000 common shares of Cronos Group (the "Shares")
were sold at a price of $9.60 per Share for aggregate gross proceeds of approximately $100.0 million (the "Offering").
The Offering was underwritten by a syndicate
co-led by GMP Securities L.P. and BMO Capital Markets and including Cormark Securities Inc., Beacon Securities Limited and PI Financial
The Company intends to use $15.0 million
of the net proceeds of the Offering for capital expenditures relating to international operations and capacity expansion, and the
remaining net proceeds of the Offering for general working capital purposes, including working capital for the Company's
international operations, and as capital on hand for potential new investment opportunities.
The Shares were offered by the Company
pursuant to the Company's effective registration statement on Form F-10 filed with the U.S. Securities and Exchange Commission
(the "SEC") and its corresponding Canadian short form prospectus filed with the securities regulatory authorities in
each of the provinces of Canada other than Qu bec (the "Securities Commissions"). A final short form prospectus
was filed with the SEC and the Securities Commissions on March 29, 2018 (the "Prospectus"). The Prospectus may be accessed
for free by visiting EDGAR on the SEC website at http://www.sec.gov or via SEDAR at www.sedar.com. Alternatively, the Company,
any underwriter or any dealer participating in the Offering will arrange to send you the Prospectus if you request it from GMP
Securities L.P. by calling toll-free at 1 (888) 301-3244 or by email at GMPECMProspectusDistribution@gmpsecurities.com or from
BMO Capital Markets, Brampton Distribution Centre C/O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario L6S 6H2
by calling (905) 791-3151 ext: 4312 or by email at torbramwarehouse@datagroup.ca.
This news release does not constitute
an offer to sell or the solicitation of an offer to buy any common shares, nor there be any sale of common shares in any jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of
All references to "$" in
this press release are to Canadian dollars.
Cronos Group is a globally diversified
and vertically integrated cannabis company with a presence across four continents. The Company operates two wholly-owned Canadian
Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals,
which was the first non-incumbent medical cannabis license granted by Health Canada, and Original BC Ltd. (British Columbia), which
is based in the Okanagan Valley. The Company has multiple international production and distribution platforms including: Germany,
Israel and Australia. The Company is rapidly expanding its global footprint as it focuses on building an international iconic brand
portfolio and developing disruptive intellectual property. Cronos Group is committed to building industry leading companies that
transform the perception of cannabis and responsibly elevate the consumer experience.
Forward-looking statements
This news release contains "forward-looking
information" and "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws.
All information contained herein that is not clearly historical in nature may constitute forward-looking information. Forward-looking
statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are
inherently subject to significant business, economic and competitive risks, uncertainties and contingencies that may cause actual
financial results, performance or achievements to be materially different from the estimated future results, performance or achievements
expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance.
Forward-looking statements in this news
release include, but are not limited to, information relating to the use of proceeds of the Offering. The intended use of the proceeds
of the Offering may change if Cronos Group elects to allocate proceeds differently from that described in this news release. Except
as required by law, Cronos Group disclaims any obligation to update or revise any forward-looking statements. Readers are cautioned
not to put undue reliance on these forward-looking statements.
Neither the TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
For further information please contact
Chief Executive Officer
Last updated: Apr 6, 2018